Genesis Care Pty Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genesis Care Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11189
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genesis Care Pty Ltd (Genesis Care) is a healthcare service provider. The company provides radiation oncology, cardiology and sleep treatment services. It offers radiotherapy, intensity modulated radiotherapy, volumetric arc therapy, stereotactic radiotherapy and radiosurgery, low dose rate and high dose rate brachytherapy, and external beam radiation therapy. Genesis Care also provides intensity modulated radiation therapy, image-guided radiation therapy, stereotactic radiosurgery, stereotactic body radiation therapy, and accelerated partial breast irradiation services; and ablation, coronary angioplasty and stenting, defribrillator implants, echocardiography, and stress echocardiography services. The company also provides accurate and rapid sleep diagnostic services, sleep physician consulting and ongoing continuous positive airway pressure therapy management services, sleep investigations and other treatment options. It has presence in Queensland, Victoria, South Australia and Western Australia, Australia; the UK; and Spain. Genesis Care is headquartered in Alexandria, New South Wales, Australia.

Genesis Care Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genesis Care Pty Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Genesis Care Acquires Portfolio Business from Elekta 11
Private Equity 12
KKR To Acquire 63% Stake In GenesisCare For Up To US$350.7 Million 12
Partnerships 13
Telix Pharma Enters into Collaboration Agreement with GenesisCare 13
Acquisition 14
Genesis Care Acquires Cancer Partners UK 14
Genesis Care Pty Ltd – Key Competitors 15
Genesis Care Pty Ltd – Key Employees 16
Genesis Care Pty Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genesis Care Pty Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Genesis Care Pty Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genesis Care Acquires Portfolio Business from Elekta 11
KKR To Acquire 63% Stake In GenesisCare For Up To US$350.7 Million 12
Telix Pharma Enters into Collaboration Agreement with GenesisCare 13
Genesis Care Acquires Cancer Partners UK 14
Genesis Care Pty Ltd, Key Competitors 15
Genesis Care Pty Ltd, Key Employees 16
Genesis Care Pty Ltd, Subsidiaries 17

List of Figures
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genesis Care Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genesis Care Pty Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genesis Care Pty Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tillotts Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of vari …
  • Diehl Stiftung & Co. KG:企業の戦略・SWOT・財務情報
    Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PGE Polska Grupa Energetyczna SA (PGE):電力:M&Aディール及び事業提携情報
    Summary PGE Polska Grupa Energetyczna SA (PGE SA) is a state owned energy utility. It generates, trades, transmits, and distributes electricity. The company carries out lignite mining activities, electricity generation from fossil fuels (lignite, hard coal, and natural gas) and renewable energy sour …
  • OJSC AK BARS Bank:企業の戦略・SWOT・財務情報
    OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report Summary OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Softchoice Corporation:企業の戦略・SWOT・財務情報
    Softchoice Corporation - Strategy, SWOT and Corporate Finance Report Summary Softchoice Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • 21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …
  • Qatar Petroleum-石油・ガス分野:企業M&A・提携分析
    Summary Qatar Petroleum (QP) is a state-owned oil and gas company. The company, along with subsidiaries, affiliates and joint ventures, undertake the exploration, drilling, production, storage, transportation, marketing and sale of crude oil, natural gas and gas liquids, liquefied natural gas (LNG), …
  • Protagonist Therapeutics Inc (PTGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-prote …
  • MRC Global Inc (MRC)-石油・ガス分野:企業M&A・提携分析
    Summary MRC Global Inc (MRC) is a provider of pipe, valves and fittings. Its product portfolio include carbon steel pipe, carbon steel fittings and flanges, valve automation, stainless and alloy pipe, stainless and alloy fittings and flanges, industrial products, specialty products, oilfield product …
  • Active Biotech AB (ACTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company’s key products in development include Laquinimod (neurodegenerative diseases); Anyara (cancer); Tasqu …
  • Gateway Lifestyle Group:企業の戦略・SWOT・財務情報
    Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report Summary Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NicozDiamond Insurance Limited:企業の戦略・SWOT・財務分析
    NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • DEA Deutsche Erdoel AG:石油・ガス:M&Aディール及び事業提携情報
    Summary DEA Deutsche Erdoel AG (DEA), a subsidiary of Letterone Holdings S.A., is an upstream company that explores for and produces oil and natural gas. The company operates onshore and offshore projects in Egyptian Nile delta, Mittelplate Island and Norwegian coast line and other regions. It also …
  • Hermes International SA:企業の戦略・SWOT・財務分析
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Burger-In Oy:企業の戦略・SWOT・財務情報
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析
    Summary Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytica …
  • Strategic Resources Inc (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Pharmicell Co Ltd (005690):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmicell Co Ltd (Pharmicell), formerly Yuhaw Trade Co Ltd is a biopharmaceutical company that discovers, develops, and commercializes stem cell drugs. The company offers pipeline products such as Cellgram_AMI a heart disease drug, Cellgram_Lung a pulmonary disease drug, and Cellgram_IS and …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆